1. Home
  2. RXRX vs ACAD Comparison

RXRX vs ACAD Comparison

Compare RXRX & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • ACAD
  • Stock Information
  • Founded
  • RXRX 2013
  • ACAD 1993
  • Country
  • RXRX United States
  • ACAD United States
  • Employees
  • RXRX N/A
  • ACAD N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • RXRX Health Care
  • ACAD Health Care
  • Exchange
  • RXRX Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • RXRX 2.6B
  • ACAD 2.8B
  • IPO Year
  • RXRX 2021
  • ACAD 2004
  • Fundamental
  • Price
  • RXRX $6.53
  • ACAD $17.57
  • Analyst Decision
  • RXRX Buy
  • ACAD Buy
  • Analyst Count
  • RXRX 5
  • ACAD 19
  • Target Price
  • RXRX $8.75
  • ACAD $26.17
  • AVG Volume (30 Days)
  • RXRX 15.7M
  • ACAD 4.3M
  • Earning Date
  • RXRX 02-25-2025
  • ACAD 02-25-2025
  • Dividend Yield
  • RXRX N/A
  • ACAD N/A
  • EPS Growth
  • RXRX N/A
  • ACAD N/A
  • EPS
  • RXRX N/A
  • ACAD 0.78
  • Revenue
  • RXRX $65,184,000.00
  • ACAD $929,236,000.00
  • Revenue This Year
  • RXRX $60.17
  • ACAD $36.78
  • Revenue Next Year
  • RXRX $19.88
  • ACAD $8.19
  • P/E Ratio
  • RXRX N/A
  • ACAD $22.63
  • Revenue Growth
  • RXRX 37.64
  • ACAD 47.06
  • 52 Week Low
  • RXRX $5.60
  • ACAD $14.15
  • 52 Week High
  • RXRX $15.74
  • ACAD $29.29
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 45.33
  • ACAD 52.06
  • Support Level
  • RXRX $6.33
  • ACAD $16.61
  • Resistance Level
  • RXRX $6.96
  • ACAD $18.23
  • Average True Range (ATR)
  • RXRX 0.56
  • ACAD 0.74
  • MACD
  • RXRX -0.11
  • ACAD -0.05
  • Stochastic Oscillator
  • RXRX 13.41
  • ACAD 36.59

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Share on Social Networks: